2,691
Views
53
CrossRef citations to date
0
Altmetric
Research Article

Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma

, , , &
Pages 1171-1183 | Received 01 Apr 2015, Accepted 05 Apr 2015, Published online: 03 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (13)

Chaemin Lim, Yuseon Shin, Kioh Kang, Patihul Husni, Dayoon Lee, Sehwa Lee, Han-Gon Choi, Eun Seong Lee, Yu Seok Youn & Kyung Taek Oh. (2023) Effects of PEG-Linker Chain Length of Folate-Linked Liposomal Formulations on Targeting Ability and Antitumor Activity of Encapsulated Drug. International Journal of Nanomedicine 18, pages 1615-1630.
Read now
Sibgha Batool, Saba Sohail, Fakhar ud Din, Ali H. Alamri, Ahmad S. Alqahtani, Mohammad A. Alshahrani, Mohammed A. Alshehri & Han Gon Choi. (2023) A detailed insight of the tumor targeting using nanocarrier drug delivery system. Drug Delivery 30:1.
Read now
Wen Weng, Qilong Wang, Chunmei Wei, Michael Adu-Frimpong, Elmurat Toreniyazov, Hao Ji, Jiangnan Yu & Ximing Xu. (2021) Mixed micelles for enhanced oral bioavailability and hypolipidemic effect of liquiritin: preparation, in vitro and in vivo evaluation. Drug Development and Industrial Pharmacy 47:2, pages 308-318.
Read now
Kamel S. Ahmed, Sun Changling, Xiaotian Shan, Jing Mao, Lipeng Qiu & Jinghua Chen. (2020) Liposome-based codelivery of celecoxib and doxorubicin hydrochloride as a synergistic dual-drug delivery system for enhancing the anticancer effect. Journal of Liposome Research 30:3, pages 285-296.
Read now
Xueyan Liu, Liangke Zhang, Wengao Jiang, Zhangyou Yang, Zongjie Gan, Chao Yu, Ran Tao & Huali Chen. (2020) In vitro and in vivo evaluation of liposomes modified with polypeptides and red cell membrane as a novel drug delivery system for myocardium targeting. Drug Delivery 27:1, pages 599-606.
Read now
Bruna dos Santos Rodrigues, Sushant Lakkadwala, Takahisa Kanekiyo & Jagdish Singh. (2019) Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties. International Journal of Nanomedicine 14, pages 6497-6517.
Read now
Yuanyuan Wang, Min Fu, Jingjing Liu, Yining Yang, Yibin Yu, Jinyu Li, Weisan Pan, Lei Fan, Guiru Li, Xuetao Li & Xiaobo Wang. (2019) Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer. International Journal of Nanomedicine 14, pages 4071-4090.
Read now
Jiongxi Lei, Shuangchen Cong, Maoyuan Song, Wenxi Zhang, Guanghua Peng, Xinru Li & Yan Liu. (2018) Combination of doxorubicin with harmine-loaded liposomes exerting synergistic antitumor efficacy. Drug Development and Industrial Pharmacy 44:4, pages 570-581.
Read now
Xin Wang, Hua Huang, Liangke Zhang, Yan Bai & Huali Chen. (2017) PCM and TAT co-modified liposome with improved myocardium delivery: in vitro and in vivo evaluations. Drug Delivery 24:1, pages 339-345.
Read now
Jian Hou, Jing Wang, E. Sun, Lei Yang, Hong-Mei Yan, Xiao-Bin Jia & Zhen-Hai Zhang. (2016) Preparation and evaluation of icariside II-loaded binary mixed micelles using Solutol HS15 and Pluronic F127 as carriers. Drug Delivery 23:9, pages 3248-3256.
Read now
Huipeng Li, Dongfen Yuan, Minjie Sun & Qineng Ping. (2016) Effect of ligand density and PEG modification on octreotide-targeted liposome via somatostatin receptor in vitro and in vivo. Drug Delivery 23:9, pages 3562-3572.
Read now
Juan Li, Fengshan Wang, Deqing Sun & Rongmei Wang. (2016) A review of the ligands and related targeting strategies for active targeting of paclitaxel to tumours. Journal of Drug Targeting 24:7, pages 590-602.
Read now

Articles from other publishers (40)

Aswathi R. Hegde, Milan Paul, Soniya Kumbham, Amrita Arup Roy, Sheikh F. Ahmad, Harendra Parekh, Swati Biswas & Srinivas Mutalik. (2023) Ameliorative anticancer effect of dendrimeric peptide modified liposomes of letrozole: In vitro and in vivo performance evaluations. International Journal of Pharmaceutics 648, pages 123582.
Crossref
Akmal M. Asrorov, Huiyuan Wang, Meng Zhang, Yonghui Wang, Yang He, Mirkomil Sharipov, Abulimiti Yili & Yongzhuo Huang. (2023) Cell penetrating peptides: Highlighting points in cancer therapy. Drug Development Research 84:6, pages 1037-1071.
Crossref
Diego Salas Sanzana, Emilia Flores Faúndez, Jaime Meléndez & Marco Soto-Arriaza. (2023) Increased delivery and cytotoxicity of doxorubicin in HeLa cells using the synthetic cationic peptide pEM-2 functionalized liposomes. Colloids and Surfaces B: Biointerfaces 228, pages 113420.
Crossref
Federica Foglietta, Annalisa Bozza, Chiara Ferraris, Luigi Cangemi, Valentina Bordano, Loredana Serpe, Katia Martina, Loretta Lazzarato, Stefania Pizzimenti, Margherita Grattarola, Marie Angele Cucci, Chiara Dianzani & Luigi Battaglia. (2023) Surface Functionalised Parenteral Nanoemulsions for Active and Homotypic Targeting to Melanoma. Pharmaceutics 15:5, pages 1358.
Crossref
Mehrdad Hashemi, Fatemeh Ghadyani, Sahar Hasani, Yeganeh Olyaee, Behnaz Raei, Marzieh Khodadadi, Maryam Fallah Ziyarani, Fatemeh A. Basti, Alireza Tavakolpournegari, Arash Matinahmadi, Shokooh Salimimoghadam, Amir Reza Aref, Afshin Taheriazam, Maliheh Entezari & Yavuz Nuri Ertas. (2023) Nanoliposomes for doxorubicin delivery: Reversing drug resistance, stimuli-responsive carriers and clinical translation. Journal of Drug Delivery Science and Technology 80, pages 104112.
Crossref
Zeqi Wang, Yu Yu, Chuqiao Wang, Jin Li & Yan Pang. (2022) Advances in the Application of Nanomaterials to the Treatment of Melanoma. Pharmaceutics 14:10, pages 2090.
Crossref
Elham Kamal Kazemi, Fereydoon Abedi-Gaballu, Tala Farid Mohammad Hosseini, Ali Mohammadi, Behzad Mansoori, Gholamreza Dehghan, Behzad Baradaran & Nader Sheibani. (2022) Glimpse into the Cellular Internalization and Intracellular Trafficking of Lipid- Based Nanoparticles in Cancer Cells. Anti-Cancer Agents in Medicinal Chemistry 22:10, pages 1897-1912.
Crossref
Yi Yang & Wenbo Zhan. (2022) Role of Tissue Hydraulic Permeability in Convection-Enhanced Delivery of Nanoparticle-Encapsulated Chemotherapy Drugs to Brain Tumour. Pharmaceutical Research 39:5, pages 877-892.
Crossref
Lijie Li, Qi Zhan, Kaikai Yi, Ning Chen, Xueping Li, Shixue Yang, Xin Hou, Jin Zhao, Xubo Yuan & Chunsheng Kang. (2022) Engineering Lipusu with lysophosphatidylcholine for improved tumor cellular uptake and anticancer efficacy. Journal of Materials Chemistry B 10:11, pages 1833-1842.
Crossref
Diana Salvador, Verónica Bastos & Helena Oliveira. (2021) Hyperthermia Enhances Doxorubicin Therapeutic Efficacy against A375 and MNT-1 Melanoma Cells. International Journal of Molecular Sciences 23:1, pages 35.
Crossref
Ejaj Ahmad, Asgar Ali, Munazza Tamkeen Fatima, Nimisha, Apurva, Arun Kumar, Mamta P. Sumi, Real Sumayya Abdul Sattar, Bhawna Mahajan & Sundeep Singh Saluja. (2021) Ligand decorated biodegradable nanomedicine in the treatment of cancer. Pharmacological Research 167, pages 105544.
Crossref
Farshad Mirzavi, Mehdi Barati, Anvar Soleimani, Roghayyeh Vakili-Ghartavol, Mahmoud Reza Jaafari & Mohammad Soukhtanloo. (2021) A review on liposome-based therapeutic approaches against malignant melanoma. International Journal of Pharmaceutics 599, pages 120413.
Crossref
Julian D. Torres-Vanegas, Juan C. Cruz & Luis H. Reyes. (2021) Delivery Systems for Nucleic Acids and Proteins: Barriers, Cell Capture Pathways and Nanocarriers. Pharmaceutics 13:3, pages 428.
Crossref
Muhammad Muzamil Khan, Nina Filipczak & Vladimir P. Torchilin. (2021) Cell penetrating peptides: A versatile vector for co-delivery of drug and genes in cancer. Journal of Controlled Release 330, pages 1220-1228.
Crossref
Md. Habban Akhter, Sarwar Beg, Mohammed Tarique, Arshi Malik, Sarah Afaq, Hani Choudhry & Salman Hosawi. (2021) Receptor-based targeting of engineered nanocarrier against solid tumors: Recent progress and challenges ahead. Biochimica et Biophysica Acta (BBA) - General Subjects 1865:2, pages 129777.
Crossref
Jafrin Jobayer Sonju, Achyut Dahal, Sitanshu S. Singh & Seetharama D. Jois. (2021) Peptide-functionalized liposomes as therapeutic and diagnostic tools for cancer treatment. Journal of Controlled Release 329, pages 624-644.
Crossref
Vivek Makwana, Jasmine Karanjia, Thomas Haselhorst, Shailendra Anoopkumar-Dukie & Santosh Rudrawar. (2021) Liposomal doxorubicin as targeted delivery platform: Current trends in surface functionalization. International Journal of Pharmaceutics 593, pages 120117.
Crossref
Ghassem Amoabediny, Ghazal Rastegar, Mahin Maleki, Dina Jafari, Zeynab Amoabediny, Fardin Rahimi & Mina Khodarahmi. 2021. Cancer Nanotheranostics. Cancer Nanotheranostics 31 52 .
Salman Ahmad Mustfa, Eleonora Maurizi, John McGrath & Ciro Chiappini. (2020) Nanomedicine Approaches to Negotiate Local Biobarriers for Topical Drug Delivery. Advanced Therapeutics 4:1, pages 2000160.
Crossref
Bruna dos Santos Rodrigues, Takahisa Kanekiyo & Jagdish Singh. (2020) In vitro and in vivo characterization of CPP and transferrin modified liposomes encapsulating pDNA. Nanomedicine: Nanotechnology, Biology and Medicine 28, pages 102225.
Crossref
Kongfang He, Jingjing Liu, Yan Gao, Yanyun Hao, Xuehua Yang & Guihua Huang. (2020) Preparation and Evaluation of Stearylamine-Bearing Pemetrexed Disodium-Loaded Cationic Liposomes In Vitro and In Vivo. AAPS PharmSciTech 21:5.
Crossref
Silvia Zappavigna, Marianna Abate, Alessia Maria Cossu, Sara Lusa, Virginia Campani, Lorena Scotti, Amalia Luce, Ali Munaim Yousif, Francesco Merlino, Paolo Grieco, Giuseppe De Rosa & Michele Caraglia. (2019) Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells. Journal of Oncology 2019, pages 1-14.
Crossref
Vivian Juang, Chih‐Hsien Chang, Chen‐Shen Wang, Hsin‐Ell Wang & Yu‐Li Lo. (2019) pH‐Responsive PEG‐Shedding and Targeting Peptide‐Modified Nanoparticles for Dual‐Delivery of Irinotecan and microRNA to Enhance Tumor‐Specific Therapy. Small 15:49, pages 1903296.
Crossref
Meijia Song, Yan Liang, Keke Li, Jing Zhang, Nan Zhang, Baocheng Tian & Jingtian Han. (2019) Hyaluronic acid modified liposomes for targeted delivery of doxorubicin and paclitaxel to CD44 overexpressing tumor cells with improved dual-drugs synergistic effect. Journal of Drug Delivery Science and Technology 53, pages 101179.
Crossref
Xi Wang, Yarong Zhao, Shiyan Dong, Robert J. Lee, Dongsheng Yang, Huan Zhang & Lesheng Teng. (2019) Cell-Penetrating Peptide and Transferrin Co-Modified Liposomes for Targeted Therapy of Glioma. Molecules 24:19, pages 3540.
Crossref
Linlin Ma, Xiaoyun Wang, Jinglei Wu, Dongdong Zhang, Lin Zhang, Xinran Song, Huoyan Hong, Chuanglong He, Xiumei Mo, Sufang Wu, Guoyin Kai & Hongsheng Wang. (2019) Polyethylenimine and sodium cholate-modified ethosomes complex as multidrug carriers for the treatment of melanoma through transdermal delivery. Nanomedicine 14:18, pages 2395-2408.
Crossref
Sara Al Basha, Najla Salkho, Sarah Dalibalta & Ghaleb Adnan Husseini. (2019) Liposomes in Active, Passive and Acoustically-Triggered Drug Delivery. Mini-Reviews in Medicinal Chemistry 19:12, pages 961-969.
Crossref
Kamel S. Ahmed, Xiaotian Shan, Jing Mao, Lipeng Qiu & Jinghua Chen. (2019) Derma roller® microneedles-mediated transdermal delivery of doxorubicin and celecoxib co-loaded liposomes for enhancing the anticancer effect. Materials Science and Engineering: C 99, pages 1448-1458.
Crossref
Intouch Sakpakdeejaroen, Sukrut Somani, Partha Laskar, Margaret Mullin & Christine Dufès. (2019) Transferrin‐bearing liposomes entrapping plumbagin for targeted cancer therapy. Journal of Interdisciplinary Nanomedicine 4:2, pages 54-71.
Crossref
Josef Jampílek & Katarína Kráľová. 2019. Nanoarchitectonics in Biomedicine. Nanoarchitectonics in Biomedicine 219 294 .
Wenbo Zhan & Chi-Hwa Wang. (2018) Convection enhanced delivery of liposome encapsulated doxorubicin for brain tumour therapy. Journal of Controlled Release 285, pages 212-229.
Crossref
Shahryar Khoshtinat Nikkhoi, Fatemeh Rahbarizadeh, Davoud Ahmadvand & Seyed Moein Moghimi. (2018) Multivalent targeting and killing of HER2 overexpressing breast carcinoma cells with methotrexate-encapsulated tetra-specific non-overlapping variable domain heavy chain anti-HER2 antibody-PEG-liposomes: In vitro proof-of-concept. European Journal of Pharmaceutical Sciences 122, pages 42-50.
Crossref
Yaqin Zhu, Jan Feijen & Zhiyuan Zhong. (2018) Dual-targeted nanomedicines for enhanced tumor treatment. Nano Today 18, pages 65-85.
Crossref
Franciele M. Pelissari, Iramaia A. Neri-Numa, Gustavo Molina, Danielle C. Ferreira & Glaucia Pastore. 2018. Applications of Nanocomposite Materials in Drug Delivery. Applications of Nanocomposite Materials in Drug Delivery 431 468 .
Behdokht Bahrami, Mohammad Hojjat-Farsangi, Hamed Mohammadi, Enayat Anvari, Ghasem Ghalamfarsa, Mehdi Yousefi & Farhad Jadidi-Niaragh. (2017) Nanoparticles and targeted drug delivery in cancer therapy. Immunology Letters 190, pages 64-83.
Crossref
Hongyun Wang, Guodong Sun, Zhigang Zhang & Yang Ou. (2017) Transcription activator, hyaluronic acid and tocopheryl succinate multi-functionalized novel lipid carriers encapsulating etoposide for lymphoma therapy. Biomedicine & Pharmacotherapy 91, pages 241-250.
Crossref
Chang Hyun Kim, Sang Gon Lee, Myung Joo Kang, Sangkil Lee & Young Wook Choi. (2017) Surface modification of lipid-based nanocarriers for cancer cell-specific drug targeting. Journal of Pharmaceutical Investigation 47:3, pages 203-227.
Crossref
Yuping Wei, Liang Zhang, Yankai Fu & Xia Xu. (2017) Rapid delivery of paclitaxel with an organic solvent-free system based on a novel cell penetrating peptide for suppression of tumor growth. Journal of Materials Chemistry B 5:37, pages 7768-7774.
Crossref
Kaisar Raza, Nitesh Kumar, Charu Misra, Lokesh Kaushik, Santosh Kumar Guru, Pramod Kumar, Ruchi Malik, Shashi Bhushan & O.P. Katare. (2016) Dextran-PLGA-loaded docetaxel micelles with enhanced cytotoxicity and better pharmacokinetic profile. International Journal of Biological Macromolecules 88, pages 206-212.
Crossref
Vinoth-Kumar Lakshmanan. (2016) Therapeutic efficacy of nanomedicines for prostate cancer: An update. Investigative and Clinical Urology 57:1, pages 21.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.